Annovis Bio receives noncompliance notification from NYSE

Annovis Bio (ANVS) announced that it received notice from the NYSE that it is no longer in compliance with the NYSE continued listing standards set forth in Section 802.01B of the NYSE’s Listed Company Manual due to the fact that the company’s average global market capitalization over a consecutive 30 trading-day period was less than $50M while its stockholders’ equity was less than $50M.